NeuroSense Therapeutics Other Current Assets

NeuroSense Therapeutics (NRSN) currently reports a other current assets of $580K as of December 2025. That compares with $860K in the prior-year period — down 32.7% year over year. Use the charts on this page to explore NeuroSense Therapeutics's other current assets history and peer comparisons.

NeuroSense Therapeutics's other current assets decreased from $860K to $580K — a 32.7% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NeuroSense Therapeutics reported $580K in other current assets as of December 2025. That compares with $860K in the prior-year period — down 32.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $580K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NeuroSense Therapeutics, and consider following NRSN for alerts when major investors trade the stock.